Pfizer Booster Dose Authorization From US FDA Has Age Caveat: At-Risk Populations 18 And Up

Age limit wasn’t part of advisory committee’s vote on third shot of the COVID vaccine, but aligns with concerns about myocarditis in younger recipients.